Treating Early HER2+ Breast Cancer: KATHERINE
5:42
Adjuvant T-DM1 for HER 2+ Breast Cancer: Critical Data From The KATHERINE Study
55:23
Breast Cancer Update with Dr. Parvin Peddi
30:50
Emerging Experts: A Discussion With Tarantino on HER2-Low Breast Cancer and Antibody-Drug Conjugates
3:22
KADCYLA| FINAL KADCYLA| TDM-1| SIDE EFFECTS| CHEMOTALK | CHEMO JOURNEY | BREAST CANCER STORY
6:40
HER2+ Breast Cancer: Managing Patients on T-DM1
17:05
Ce qu’on ne vous dit JAMAIS sur la Fratrie avec le Dr. Robert Neuburger
5:47
The meaning of residual disease in breast cancer
22:07